APA (7th ed.) Citation

W, B., A, G., A, M., J, M., J, S., M, S., . . . A, R. (2025). MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model. International journal of molecular sciences, 26(2), . https://doi.org/10.3390/ijms26020834

Chicago Style (17th ed.) Citation

W, Bębenek, Gajek A, Marczak A, Malý J, Smejkal J, Statkiewicz M, Rusetska N, Bryś M, and Rogalska A. "MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model." International Journal of Molecular Sciences 26, no. 2 (2025). https://doi.org/10.3390/ijms26020834.

MLA (9th ed.) Citation

W, Bębenek, et al. "MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model." International Journal of Molecular Sciences, vol. 26, no. 2, 2025, https://doi.org/10.3390/ijms26020834.